1-2 of 2
David J. Carlile
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Randomized phase 2 study of obinutuzumab monotherapy in symptomatic, previously untreated chronic lymphocytic leukemia

Clinical Trials & Observations
John C. Byrd, Joseph M. Flynn, Thomas J. Kipps, Michael Boxer, Kathryn S. Kolibaba, David J. Carlile, Guenter Fingerle-Rowson, Nicola Tyson, Jamie Hirata, Jeff P. Sharman
Journal: Blood
Blood (2016) 127 (1): 79–86.
https://doi.org/10.1182/blood-2015-03-634394
Published: 2016
Journal Articles

A phase 1 study of obinutuzumab induction followed by 2 years of maintenance in patients with relapsed CD20-positive B-cell malignancies

Clinical Trials & Observations
Laurie H. Sehn, Sarit E. Assouline, Douglas A. Stewart, Joy Mangel, Randy D. Gascoyne, Gregg Fine, Susan Frances-Lasserre, David J. Carlile, Michael Crump
Journal: Blood
Blood (2012) 119 (22): 5118–5125.
https://doi.org/10.1182/blood-2012-02-408773
Published: 2012